Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif., Nov. 14, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update. The Company continues to remain focused on three key business initiatives. Successful execution of the Evie Ring direct-to-consumer business (D2C) following the September 17th back-in-sto

New hardware boasts significant improvements to reduce noise and generate higher fidelity signals PLEASANTON, Calif., Nov. 7, 2024 /PRNewswire/ -- Movano Health Inc. (NASDAQ:MOVE) announced today that it has tested its newly developed blood pressure wrist wearable as part of its November 5th and 6th hypoxia clinical trial that took place at the University of California, San Francisco. The updated device features an additional 12 mmWave antennas which together with Movano Health's custom IC delivers enhanced data collection with less impact of placement while also featuring a slimmer design, making it easier and more comfortable to wear. In addition, the new wearable monitors a host of other

Company Continues to Work with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif., Nov. 4, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) (the "Company") provided an update on an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split. Based on its preliminary investigation, the Company believes that between the announcement of the reverse split on October 25, 2024, and its effective date on October 2

Company remains optimistic on the potential for this pioneering healthcare solution PLEASANTON, Calif., Nov. 4, 2024 /PRNewswire/ -- Movano Health (NASDAQ: MOVE) announced today that it has submitted a complete response package to the FDA as part of the final phase of the Company's 510(k) application review of the EvieMED Ring. The Company remains optimistic on EvieMED's potential for 510(k) clearance. "Our team has worked diligently to provide a thorough response to the Agency's questions," said John Mastrototaro, President and CEO of Movano Health. "We look forward to the su

Company Communicating with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif., Oct. 31, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) (the "Company") announced today that it has opened an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split. "We are committed to transparency and protecting the interests of our Company and shareholders," said John Mastrototaro, President and CEO of Movano Health. "

Collaboration Will Expand Awareness of Movano's Female First Wearable to D'Amelio's 12 Million Social Media Followers PLEASANTON, Calif., Oct. 30, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE) today announced its first brand partnership with digital creator, wife, mom and entrepreneur Heidi D'Amelio. An icon in the wellness, fashion and beauty space, D'Amelio will share her experiences with Movano's Evie Ring with her more than 12 million Instagram and TikTok followers and also provide product feedback to help the Movano team fine-tune its roadmap for ongoing upgrades to the Evie app.

Shares Expected to Begin Trading on Split-Adjusted Basis on October 29, 2024 PLEASANTON, Calif., Oct. 25, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that it will implement a 1-for-15 reverse stock split of the issued shares of its common stock (the "Reverse Stock Split"), effective at 12:01 a.m. Eastern time on October 29, 2024. The Company's common stock is expected to begin trading on a split-adjusted basis when the market opens on Tuesday, October 29, 2024, and will continue to trade on The Nasdaq Capital Market under the symbol "MOVE." The new CUSIP number for the common stock will be 62459M 206.

A successful response to requests for additional information would bring the Company one step closer to introducing this pioneering healthcare product to the market PLEASANTON, Calif., Oct. 24, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that it plans to submit updated responses next week to all clarifying questions that it recently received from the FDA as part of the final phase of the Company's 510(k) application review. The Company secured a positive resolution this summer after responding to initial FDA questions related to EvieMED's wellness features and metrics and remains optimistic on EvieMED's potential for 510(k) clearance.

The Company continues to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif., Oct. 10, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that the Company recently received additional clarifying questions from the FDA related to medical aspects of the EvieMED Ring, as part of the final phase of the Company's 510(k) application review process. The Company secured a positive resolution this summer after responding to initial FDA questions related to EvieMED's wellness features and metrics and remains optimistic on EvieMED's potential for 510(k) clearance.

Orders Reopen with Enhancements to AI Powered Health Insights, Sleep and Heart Rate Measurements and More PLEASANTON, Calif., Sept. 17, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE) today announced the immediate availability of its Evie Ring, the first smart ring designed specifically for women. The ring features the same industry-first, award-winning open design that accommodates fluctuations in finger size, and is accompanied by an updated app that enhances users' ability to track and understand key metrics vital to their health and wellness. Relaunching after a hiatus to

4 - Movano Inc. (0001734750) (Issuer)

4 - Movano Inc. (0001734750) (Issuer)

4 - Movano Inc. (0001734750) (Issuer)

4 - Movano Inc. (0001734750) (Issuer)

4 - Movano Inc. (0001734750) (Issuer)

4 - Movano Inc. (0001734750) (Issuer)

4 - Movano Inc. (0001734750) (Issuer)

4 - Movano Inc. (0001734750) (Issuer)

10-Q - Movano Inc. (0001734750) (Filer)

8-K - Movano Inc. (0001734750) (Filer)

8-K - Movano Inc. (0001734750) (Filer)

424B5 - Movano Inc. (0001734750) (Filer)

S-8 - Movano Inc. (0001734750) (Filer)

8-K - Movano Inc. (0001734750) (Filer)

10-Q - Movano Inc. (0001734750) (Filer)

8-K - Movano Inc. (0001734750) (Filer)

8-K - Movano Inc. (0001734750) (Filer)

424B5 - Movano Inc. (0001734750) (Filer)

SC 13G - Movano Inc. (0001734750) (Subject)

SC 13G/A - Movano Inc. (0001734750) (Subject)

SC 13G - Movano Inc. (0001734750) (Subject)

SC 13G - Movano Inc. (0001734750) (Subject)

Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif., Nov. 14, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update. The Company continues to remain focused on three key business initiatives. Successful execution of the Evie Ring direct-to-consumer business (D2C) following the September 17th back-in-sto

Prepares for September 17, 2024, Evie Ring back in stock dateAnnounces brand partnership with digital creator Heidi D'AmelioFocuses on launch of EvieMED and securing B2B opportunitiesConference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif., Aug. 14, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, reported second quarter 2024 results and provided a business update. Following the successful close of the Company's April 2024 $24.1 million private placement that included a seed investment from a tier 1 multi-billion dollar medical device

Company continues to work with FDA to bring this pioneering healthcare product to market PLEASANTON, Calif., Aug. 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) plans to meet with the FDA in mid-August, as part of the Company's ongoing process to secure a 510(k) clearance for the EvieMED Ring, a wearable designed to not only provide medical device functionality through its pulse oximetry feature, but also offer numerous wellness metrics related to sleep, activity and mood/energy/symptom logging. On April 21, 2024, Movano Health filed an updated 510(k) for the EvieMED Ring's pulse oximetry feature. At the time of the filing and based on prior interactions with the agency and its protoco

Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif., Aug. 5, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, today announced that it will report second quarter 2024 financial and operating results on Wednesday, August 14, 2024, after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same day at 2:00 pm PT/5:00 pm ET. Attendees can access the live webcast here or on the investors section of Movano Health's website at https://ir.movano.com. The c

Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance processPlans launch of Evie Med and focuses on B2B opportunitiesPlans arterial blood pressure study for JuneConference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif., May 15, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, reported first quarter 2024 results and provided a business update. Following the successful close of its recent $24 million private placement that included a seed investment from a tier 1 multi-billion dollar medical device company, Movan

Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif., May 6, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, today announced that it will report first quarter 2024 financial and operating results on Wednesday May 15, 2024, after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same day at 2:00 pm PT/5:00 pm ET. Attendees can access the live webcast here or on the investors section of Movano Health's website at https://ir.movano.com. The confere

Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from members of Movano Health's management team and board of directors Hosting conference call on April 4, 2024 at 2:00 PM PT/5:00 PM ET PLEASANTON, Calif., April 2, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, today has agreed to sell approximately 45 million units in a $24 million private placement, with each unit consisting of one share of the Company's common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that includes a tier-one multi-billion dolla

Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif., April 2, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, today announced that it will report fourth quarter 2023 financial and operating results on Thursday, April 4, 2024, after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same day at 2:00 pm PT/5:00 pm ET. Attendees can access the live webcast here or on the investors section of Movano Health's website at https://ir.movano.com. The con

PLEASANTON, Calif., Aug. 8, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it will report second quarter 2023 financial and operating results on Monday, August 14, 2023. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 2:00 p.m. PDT (5:00 p.m. EDT).  Attendees can access the live webcast here or on the investors section of Movano Health's webs

Conference call begins at 2:00 p.m. Pacific time today PLEASANTON, Calif., Nov. 14, 2022 /PRNewswire/ -- Today, Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medical and consumer devices, reported financial results for the three months ending September 30, 2022 and provided a business update. Highlights from the third quarter and recent weeks include the following: Movano Health continues to expect to test the wearability and functionality of its smart device in beta programs with multiple strategic partners b

Gainers Spectaire Holdings (NASDAQ:SPEC) stock moved upwards by 148.9% to $0.85 during Friday's pre-market session. The company's market cap stands at $15.6 million. Ascent Solar Technologies (NASDAQ:ASTI) stock rose 35.31% to $0.15. The market value of their outstanding shares is at $13.2 million. Sequans Communications (NYSE:SQNS) shares moved upwards by 14.46% to $0.55. The company's market cap stands at $34.0 million. The company's, Q1 earnings came out 3 days ago. Minim (NASDAQ:MINM) shares increased by 10.13% to $3.15. The market value of their outstanding shares is at $8.8 million. DatChat (NASDAQ:DATS) shares rose 8.15% to $1.34. The market value of their outstanding shares is a

Movano Health (Nasdaq: MOVE) announced major advances in the accuracy of its heart rate in motion algorithm following the implementation of deep learning into the processing. The Company recently released an engineering accuracy study directed by Movano Health Founder and CTO Michael Leabman, Enhanced Heart Rate in Motion Accuracy with the Evie Ring Using Advanced Deep Learning Algorithms, which demonstrates the value of deep learning integration into heart rate (HR) algorithms for improved accuracy.

Pioneering partnership advances innovative health monitoring, setting the stage for future enterprise opportunities.PLEASANTON, Calif., June 10, 2024 /PRNewswire/ -- In a strategic move that could reshape the understanding of long COVID and chronic Lyme disease, the Massachusetts Institute of Technology (MIT) has forged a partnership with Movano Health for its MAESTRO study to harness the medical grade continuous health monitoring capabilities of Movano's Evie Ring.

Gainers Ascent Solar Technologies (NASDAQ:ASTI) stock rose 21.0% to $0.16 during Thursday's pre-market session. The company's market cap stands at $4.8 million. LiveRamp Holdings (NYSE:RAMP) shares rose 14.4% to $37.0. The company's market cap stands at $2.4 billion. The company's, Q4 earnings came out yesterday. FOXO Technologies (AMEX:FOXO) stock rose 9.89% to $0.32. The company's market cap stands at $3.2 million. T Stamp (NASDAQ:IDAI) shares moved upwards by 9.33% to $0.71. The company's market cap stands at $7.5 million. Zuora (NYSE:ZUO) shares increased by 9.33% to $10.78. The company's market cap stands at $1.5 billion. As per the news, the Q1 earnings report came out yesterday.

Gainers AEye (NASDAQ:LIDR) stock rose 36.7% to $1.64 during Friday's pre-market session. The market value of their outstanding shares is at $10.6 million. Inseego (NASDAQ:INSG) shares increased by 16.66% to $4.48. The company's market cap stands at $53.2 million. As per the news, the Q1 earnings report came out yesterday. WiSA Technologies (NASDAQ:WISA) stock moved upwards by 16.44% to $3.54. The company's market cap stands at $11.3 million. SoundHound AI (NASDAQ:SOUN) stock rose 14.1% to $5.42. The market value of their outstanding shares is at $1.7 billion. The company's, Q1 earnings came out yesterday. Movano (NASDAQ:MOVE) shares moved upwards by 13.9% to $0.45. The company's market

An FDA clearance would bring Movano Health a significant step closer in its pursuit to disrupt the wearables industry while unlocking significant partnership opportunities. The Company continues to expect a decision regarding its 510(k) clearance in July 2024.

Shares of GeneDx Holdings Corp. (NASDAQ:WGS) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and raised its FY2024 sales guidance. GeneDx reported quarterly losses of 33 cents per share which beat the analyst consensus estimate of losses of 67 cents. The company reported quarterly sales of $62.422 million which beat the analyst consensus estimate of $49.463 million, according to data from Benzinga Pro. GeneDx raised its full-year 2024 revenue guidance to between $235 million and $245 million, up from $220 million to $230 million, and expanded its full-year 2024 adjusted gross margin profile to at least 60% from

Gainers Marin Software (NASDAQ:MRIN) stock increased by 35.2% to $3.53 during Tuesday's pre-market session. The market value of their outstanding shares is at $10.6 million. Auddia (NASDAQ:AUUD) shares rose 23.93% to $2.04. The market value of their outstanding shares is at $4.8 million. Blend Labs (NYSE:BLND) shares increased by 23.11% to $2.77. The company's market cap stands at $698.1 million. Movano (NASDAQ:MOVE) shares increased by 10.8% to $0.51. The company's market cap stands at $50.0 million. 908 Devices (NASDAQ:MASS) shares increased by 9.81% to $6.32. The company's market cap stands at $207.9 million. As per the news, the Q1 earnings report came out today. Aeva Technologies

Gainers UTime (NASDAQ:WTO) stock moved upwards by 12.6% to $0.26 during Friday's pre-market session. The company's market cap stands at $3.5 million. AEye (NASDAQ:LIDR) stock rose 10.78% to $1.13. The company's market cap stands at $7.3 million. BIT Mining (NYSE:BTCM) stock increased by 8.96% to $2.31. The market value of their outstanding shares is at $25.6 million. Movano (NASDAQ:MOVE) stock rose 7.35% to $0.52. The market value of their outstanding shares is at $51.0 million. Box (NYSE:BOX) shares moved upwards by 5.78% to $28.0. The market value of their outstanding shares is at $4.0 billion. Taoping (NASDAQ:TAOP) stock increased by 5.54% to $1.14. The company's market cap stands a